Vadim Gushchin, MD
Surgical Oncology · Buffalo, NYNPI 1427054568
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $854 and has fallen 69.5% since, to $260 in 2025.
Across 133 payments — averaging $28.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$874
- AbbVie$492
- E.r. Squibb & Sons, L.L.C.$402
- Intera Oncology, Inc$228
- Eisai Inc.$197
- Merck$178
- plus $1K from 27 others
Across 6 payments — averaging $5694.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$34K
What the payments were for
- Food & beverage$3,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 26 | $874 |
| AbbVie | 18 | $492 |
| E.r. Squibb & Sons, L.L.C. | 14 | $402 |
| Intera Oncology, Inc | 1 | $228 |
| Eisai Inc. | 9 | $197 |
| Merck | 10 | $178 |
| Medical Device Business Services, Inc. | 4 | $177 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
| Medtronic | 3 | $110 |
| Novartis | 6 | $105 |
| Baxter Healthcare | 2 | $96 |
| Sanofi | 4 | $80 |
| Histosonics, Inc. | 2 | $77 |
| Hologic Sales And Service, LLC | 2 | $74 |
| Bayer | 3 | $72 |
| Angiodynamics, Inc. | 3 | $66 |
| Springworks Therapeutics, Inc. | 2 | $51 |
| AstraZeneca | 2 | $46 |
| EMD Serono, Inc. | 2 | $44 |
| Covidien LP | 1 | $43 |
| Tempus AI, Inc | 1 | $28 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $23 |
| Foundation Medicine, Inc. | 1 | $23 |
| Avanos Medical | 1 | $22 |
| TEI Biosciences Inc | 1 | $21 |
| Getinge USA Sales, LLC | 1 | $21 |
| Seagen Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $17 |
| Amgen | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,829 in reported general payments places this provider in the 70th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Buffalo
- Helen CappuccinoBuffalo$70K
- Moshim KukarBuffalo$17K
- Michael NagaiBuffalo$5K
- Steven NurkinBuffalo$3K
- Sheldon FeldmanNew York$97K
- Kepal PatelNew York$94K
- Jose Alberty OllerStaten Island$63K
- Megan WinnerMineola$51K
- George PlitasNew York$39K
- James ParkNew York$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.